| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | $0.00 | $574.25K | $294.17K | $659.10K |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $7.29M | $9.34M | $12.64M | $12.47M | $10.72M | $8.55M |
| R&D | $1.91M | $2.21M | $2.52M | $2.75M | $2.34M | $2.07M |
| SG&A | $2.70M | $3.24M | $3.90M | $4.48M | $3.46M | $2.46M |
| Operating Income | -$7.29M | -$9.34M | -$12.64M | -$11.90M | -$10.42M | -$7.89M |
| Interest Expense | – | $10.11K | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$7.15M | -$13.39M | -$12.21M | -$12.03M | -$10.42M | -$7.89M |
| EPS (basic) | -10.6100 | -8.5800 | -4.8600 | -0.5900 | -0.7100 | – |
| EPS (diluted) | -10.6100 | -8.5800 | -4.8600 | -0.5900 | -0.7100 | – |
| Shares (diluted) | $673.95K | $1.56M | $2.51M | $20.54M | $14.76M | – |